all report title image

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET ANALYSIS

Hemodialysis and Peritoneal Dialysis Market, by Product Type (Device (Machines, Dialyzer, Water Treatment System, and Others) and Consumables), by Procedure (Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis) and Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD)), by End User (Home Care Setting, Hospitals, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI2327
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market Challenges And Opportunities

Hemodialysis and Peritoneal Dialysis Market Drivers

Global hemodialysis and peritoneal dialysis market growth is expected to be driver by innovative product launches by leading manufacturers, mergers and acquisitions, and initiatives by manufacturers to sustain and compete in global hemodialysis and peritoneal dialysis market. For instance, leading manufacturers such as Fresenius Medical Care AG & Co. KGaA are focusing on product launches as well as merger and acquisitions. Fresenius Medical Care supported the recommendation by the National Institute for Health and Care Excellence (NICE) to facilitate population healthcare management for UK patients with end-stage renal disease by using hemodiafiltration (HDF) rather than high-flux hemodialysis (HD) in October 2018. This is expected to boost global hemodialysis and peritoneal dialysis market growth over the forecast period.

Moreover, Fresenius Medical Care and Humacyte, Inc. entered into a strategic partnership in November 2018. Humacyte has developed HUMACYL, which is currently being investigated for vascular access for hemodialysis. Moreover, in April 2018, Fresenius Medical Care won the Red Dot Award: Product Design for the company’s 6008 CAREset bloodline system used in hemodialysis. Furthermore, Fresenius Medical Care signed an agreement to acquire NxStage Medical, Inc., (NxStage), a U.S.-based medical technology and Services Company in 2017. B. Braun Medical, Inc. signed an agreement to acquire the bloodlines business operated under the Medisystems name by NxStage Medical, Inc. In 2017 NxStage Medical, Inc. announced that the U.S. Food and Drug Administration (FDA) cleared its System One for solo home hemodialysis. These factors are expected to support global hemodialysis and peritoneal dialysis market growth over the forecast period.

Stringent regulatory policies for the approval and manufacturing, reimbursement, and risks and complications associated with dialysis treatment are expected to restrain global hemodialysis and peritoneal dialysis market growth over the forecast period.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.